Regulations.gov document
Reference 41 - Untitled Letter to Interleukin Genetics, Inc.
Supporting & Related Material · FDA-2023-N-2177 · posted May 6, 2024
Key facts
| Document ID | FDA-2023-N-2177-6891 |
|---|---|
| Title | Reference 41 - Untitled Letter to Interleukin Genetics, Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2023-N-2177 |
| Posted | May 6, 2024 |
At a glance
- 1,000+ Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: